Document is current
Any future updates will be listed below
-
Authors
Guernier-Cambert, Vanina https://orcid.org/0000-0002-0960-3874
Diefenbach-Elstob, Tanya https://orcid.org/0000-0002-7784-5111
Klotoe, Bernice J.
Burgess, Graham
Pelowa, Daniel
Dowi, Robert
Gula, Bisato
McBryde, Emma S. https://orcid.org/0000-0002-9570-9172
Refrégier, Guislaine https://orcid.org/0000-0003-3749-7981
Rush, Catherine https://orcid.org/0000-0002-3044-9488
Sola, Christophe https://orcid.org/0000-0003-4672-2140
Warner, Jeffrey https://orcid.org/0000-0002-5869-8283
-
Funding
Funding for this research was provided by:
State of Queensland | Department of Science, Information Technology and Innovation, Queensland Government
- License Information
-
More Information
Article History
Received: 21 May 2019
Accepted: 25 September 2019
First Online: 29 October 2019
Competing interests
: C. Sola is among the founders of the Beamedex SAS company that produces and commercializes the spoligotyping (TB-SPOL) kit as a “Research Use Only” assay, to be run on Luminex 200 and on MagPix devices (Luminex Corp., Austin, TX). C. Sola does not hold any share in Beamedex and does not hold any share in Luminex Corporation nor was financed by Luminex. The other investigators have no financial interest or financial conflict with the subject matter or materials discussed in this report.
